Response predictors to treatment with pegylated interferon in chronic hepatitis B

Detalhes bibliográficos
Autor(a) principal: Ferreira,Paulo Roberto Abrão
Data de Publicação: 2010
Outros Autores: Tenore,Simone de Barros
Tipo de documento: Artigo
Idioma: eng
Título da fonte: Brazilian Journal of Infectious Diseases
Texto Completo: http://old.scielo.br/scielo.php?script=sci_arttext&pid=S1413-86702010000500017
Resumo: The clinical and epidemiological importance of chronic B hepatitis is currently unquestionable as a cause of end-stage liver disease and hepatocellular carcinoma. Recently, predictors of treatment response of this disease have been studied, both before and during the course of medication. Therapy stopping rules have been proposed, which may be useful in patients presenting poor treatment tolerance. This review discusses the treatment response predictors usefulness, with emphasis on ALT, quantitative HBsAg and HBeAg, quantitative HBV-DNA and HBV genotype
id BSID-1_0605137d0ca9870d5a824607b733b167
oai_identifier_str oai:scielo:S1413-86702010000500017
network_acronym_str BSID-1
network_name_str Brazilian Journal of Infectious Diseases
repository_id_str
spelling Response predictors to treatment with pegylated interferon in chronic hepatitis Bhepatitis BHBsAgHBeAgHBV-DNApegylated interferonThe clinical and epidemiological importance of chronic B hepatitis is currently unquestionable as a cause of end-stage liver disease and hepatocellular carcinoma. Recently, predictors of treatment response of this disease have been studied, both before and during the course of medication. Therapy stopping rules have been proposed, which may be useful in patients presenting poor treatment tolerance. This review discusses the treatment response predictors usefulness, with emphasis on ALT, quantitative HBsAg and HBeAg, quantitative HBV-DNA and HBV genotypeBrazilian Society of Infectious Diseases2010-10-01info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersiontext/htmlhttp://old.scielo.br/scielo.php?script=sci_arttext&pid=S1413-86702010000500017Brazilian Journal of Infectious Diseases v.14 n.5 2010reponame:Brazilian Journal of Infectious Diseasesinstname:Brazilian Society of Infectious Diseases (BSID)instacron:BSID10.1590/S1413-86702010000500017info:eu-repo/semantics/openAccessFerreira,Paulo Roberto AbrãoTenore,Simone de Barroseng2011-01-03T00:00:00Zoai:scielo:S1413-86702010000500017Revistahttps://www.bjid.org.br/https://old.scielo.br/oai/scielo-oai.phpbjid@bjid.org.br||lgoldani@ufrgs.br1678-43911413-8670opendoar:2011-01-03T00:00Brazilian Journal of Infectious Diseases - Brazilian Society of Infectious Diseases (BSID)false
dc.title.none.fl_str_mv Response predictors to treatment with pegylated interferon in chronic hepatitis B
title Response predictors to treatment with pegylated interferon in chronic hepatitis B
spellingShingle Response predictors to treatment with pegylated interferon in chronic hepatitis B
Ferreira,Paulo Roberto Abrão
hepatitis B
HBsAg
HBeAg
HBV-DNA
pegylated interferon
title_short Response predictors to treatment with pegylated interferon in chronic hepatitis B
title_full Response predictors to treatment with pegylated interferon in chronic hepatitis B
title_fullStr Response predictors to treatment with pegylated interferon in chronic hepatitis B
title_full_unstemmed Response predictors to treatment with pegylated interferon in chronic hepatitis B
title_sort Response predictors to treatment with pegylated interferon in chronic hepatitis B
author Ferreira,Paulo Roberto Abrão
author_facet Ferreira,Paulo Roberto Abrão
Tenore,Simone de Barros
author_role author
author2 Tenore,Simone de Barros
author2_role author
dc.contributor.author.fl_str_mv Ferreira,Paulo Roberto Abrão
Tenore,Simone de Barros
dc.subject.por.fl_str_mv hepatitis B
HBsAg
HBeAg
HBV-DNA
pegylated interferon
topic hepatitis B
HBsAg
HBeAg
HBV-DNA
pegylated interferon
description The clinical and epidemiological importance of chronic B hepatitis is currently unquestionable as a cause of end-stage liver disease and hepatocellular carcinoma. Recently, predictors of treatment response of this disease have been studied, both before and during the course of medication. Therapy stopping rules have been proposed, which may be useful in patients presenting poor treatment tolerance. This review discusses the treatment response predictors usefulness, with emphasis on ALT, quantitative HBsAg and HBeAg, quantitative HBV-DNA and HBV genotype
publishDate 2010
dc.date.none.fl_str_mv 2010-10-01
dc.type.driver.fl_str_mv info:eu-repo/semantics/article
dc.type.status.fl_str_mv info:eu-repo/semantics/publishedVersion
format article
status_str publishedVersion
dc.identifier.uri.fl_str_mv http://old.scielo.br/scielo.php?script=sci_arttext&pid=S1413-86702010000500017
url http://old.scielo.br/scielo.php?script=sci_arttext&pid=S1413-86702010000500017
dc.language.iso.fl_str_mv eng
language eng
dc.relation.none.fl_str_mv 10.1590/S1413-86702010000500017
dc.rights.driver.fl_str_mv info:eu-repo/semantics/openAccess
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv text/html
dc.publisher.none.fl_str_mv Brazilian Society of Infectious Diseases
publisher.none.fl_str_mv Brazilian Society of Infectious Diseases
dc.source.none.fl_str_mv Brazilian Journal of Infectious Diseases v.14 n.5 2010
reponame:Brazilian Journal of Infectious Diseases
instname:Brazilian Society of Infectious Diseases (BSID)
instacron:BSID
instname_str Brazilian Society of Infectious Diseases (BSID)
instacron_str BSID
institution BSID
reponame_str Brazilian Journal of Infectious Diseases
collection Brazilian Journal of Infectious Diseases
repository.name.fl_str_mv Brazilian Journal of Infectious Diseases - Brazilian Society of Infectious Diseases (BSID)
repository.mail.fl_str_mv bjid@bjid.org.br||lgoldani@ufrgs.br
_version_ 1754209241498910720

Registros relacionados